Business Context and Reporting Period
Company: Axiom Intelligence Acquisition Corp 1 (SPAC)
Filing Date: May 25, 2026
Event: Entry into a Material Definitive Agreement (Business Combination Agreement) with Terra Quantum AG, a Swiss company specializing in quantum computing, quantum security, and AI-driven optimization solutions.
Transaction Structure: The SPAC will merge with a newly formed Cayman Islands subsidiary (Merger Sub), which will then merge with a Swiss holding company (Swiss HoldCo) formed by Terra Quantum shareholders. The surviving entity will be a public limited company organized under Swiss laws (PubCo).
Key Financial Metrics and Consideration
Revenue, Profit, and Cash Flow: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for either the SPAC or Terra Quantum AG.
Consideration Structure:
- SPAC Shareholders: Each SPAC Ordinary Share (including those converted from Rights) will be exchanged for one PubCo Ordinary Share.
- Terra Quantum Shareholders: Swiss HoldCo shares will be exchanged for PubCo Ordinary Shares based on an Exchange Ratio (specific ratio not disclosed in this text).
- Earnout Shares: Up to 75,000,000 additional PubCo Ordinary Shares are issuable in three tranches based on 30-day VWAP thresholds of $12.50, $15.00, and $17.50 over an eight-year period.
Material Changes and Transaction Terms
Equity Incentives: PubCo will adopt a new equity incentive plan with an initial reserve of 10% of outstanding shares on a fully diluted basis, including a 5% annual "evergreen" provision.
Board Composition: The PubCo board will consist of seven directors: five designated by Terra Quantum and two by the SPAC.
Lock-Up Agreements: Sponsor and certain Terra Quantum shareholders have agreed to lock-up periods of 180 days post-closing, unless the PubCo share price exceeds $12.00 for 20 trading days within a 30-day period.
Termination Fee: If the SPAC terminates the agreement during the Diligence Review Period due to unsatisfactory due diligence, the SPAC CEO (Douglas Ward) must pay a $15,000,000 termination fee to Terra Quantum.
Guidance, Risks, and Contingencies
Closing Conditions: The transaction is contingent upon shareholder approval from both SPAC and Terra Quantum, effectiveness of the Proxy/Registration Statement, Nasdaq listing approval, and the absence of a Material Adverse Effect.
Key Risks:
- Regulatory and Approval Risk: Failure to obtain necessary regulatory approvals or shareholder votes.
- Market Risk: Uncertainty regarding market adoption of quantum technology and rapid technological changes.
- Redemption Risk: The amount of funds available depends on SPAC shareholder redemption requests.
- Operational Risk: Ability to retain key employees and manage growth profitably.
Forward-Looking Statements: The filing contains numerous forward-looking statements regarding future results, which are subject to significant risks and uncertainties and should not be relied upon as guarantees.
Investor Verification Checklist
- Verify the specific Exchange Ratio for Terra Quantum shareholders in the definitive Proxy Statement (Form F-4).
- Review the Trust Account balance and projected redemption levels to assess post-transaction liquidity.
- Confirm the Nasdaq listing approval status for the new PubCo securities.
- Examine the fairness opinion from the independent investment banking firm referenced in the closing conditions.
- Assess the quantum technology market risks and Terra Quantum's specific commercialization progress detailed in the Registration Statement.